F-group (family)
220.1.1.1 PH
Ligands and drugs
2,245
Member domains
159
with ligand contacts (≤ 4 Å)
7.1% of members
156
with DrugDomain annotations
6.9% of members
96
with a DrugBank compound
4.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 220.1.1.1 belongs to X-group 220 PH domain-like, which binds 7.7 ligand superclasses per 20 proteins, broader than 51% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01863 | 4IP | Inositol 1,3,4,5-Tetrakisphosphate | 24 |
| DB03401 | I3P | 1D-myo-inositol 1,4,5-trisphosphate | 4 |
| DB12010 | — | Fostamatinib | 4 |
| DB14981 | IHP | Phytic acid | 4 |
| DB03344 | I5P | Inositol-(1,3,4,5,6)-Pentakisphosphate | 3 |
| DB15035 | — | — | 2 |
| DB00122 | — | Choline | 1 |
| DB00144 | — | Phosphatidyl serine | 1 |
| DB01169 | — | — | 1 |
| DB01645 | — | Genistein | 1 |
| DB01729 | I3S | 1D-myo-inositol 1,3,4-trisphosphate | 1 |
| DB02709 | — | Resveratrol | 1 |
| DB03556 | PE5 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | 1 |
| DB04530 | — | — | 1 |
| DB06486 | — | — | 1 |
| DB06589 | — | — | 1 |
| DB06641 | — | — | 1 |
| DB11093 | — | — | 1 |
| DB11348 | — | — | 1 |
| DB11703 | — | Acalabrutinib | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 4IP | INOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE | 27 |
| UNX | UNKNOWN ATOM OR ION | 13 |
| MGmetal | MAGNESIUM ION | 10 |
| 4PT | (2R)-3-{[(S)-{[(2S,3R,5S,6S)-2,6-DIHYDROXY-3,4,5-TRIS(PHOSPHONOOXY)CYCLOHEXYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-(1-HYDROXYBUTOXY)PROPYL BUTYRATE | 5 |
| IHP | INOSITOL HEXAKISPHOSPHATE | 4 |
| NAmetal | SODIUM ION | 4 |
| NXT | 4,5,6,7-tetrahydro-1-benzofuran-3-carboxylic acid | 4 |
| NYQ | 5-bromanyl-1,3-dihydroindol-2-one | 4 |
| XOO | 4-{2-[({4-[(2P)-2-(2-aminopyridin-3-yl)-5-phenyl-3H-imidazo[4,5-b]pyridin-3-yl]phenyl}methyl)amino]ethyl}-2-hydroxybenzaldehyde | 4 |
| CL | CHLORIDE ION | 3 |
| I3P | D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE | 3 |
| IP5 | (1R,2S,3R,4S,5S,6R)-6-HYDROXYCYCLOHEXANE-1,2,3,4,5-PENTAYL PENTAKIS[DIHYDROGEN (PHOSPHATE)] | 3 |
| IP9 | (2R)-3-{[(R)-{[(1S,2S,3R,4S,5S,6S)-2,6-dihydroxy-3,4,5-tris(phosphonooxy)cyclohexyl]oxy}(hydroxy)phosphoryl]oxy}propane-1,2-diyl dioctanoate | 3 |
| Q1B | 5-(trifluoromethyloxy)-1,3-dihydroindol-2-one | 3 |
| 3IS | 5-chloranyl-1,3-dihydroindol-2-one | 2 |
| 72V | 1-methylindole-2,3-dione | 2 |
| I5P | INOSITOL-(1,3,4,5,6)-PENTAKISPHOSPHATE | 2 |
| PBU | (2R)-3-{[(R)-HYDROXY{[(1R,2R,3S,4R,5R,6S)-2,3,6-TRIHYDROXY-4,5-BIS(PHOSPHONOOXY)CYCLOHEXYL]OXY}PHOSPHORYL]OXY}PROPANE-1,2-DIYL DIBUTANOATE | 2 |
| SEP | PHOSPHOSERINE | 2 |
| ZNmetal | ZINC ION | 2 |